October 13, 2017
Insys Therapeutics, Inc. (NASDAQ:INSY) just released its October 2017 investor presentation, and we think it's worth taking a look! Scroll through the slides below for an in-depth look at what's going on at Insys.
To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!
Read more articles tagged:
50 Blue Chip Stocks Worth Less than Half as Much a...
September 19, 2018
5 of Today's Biggest Marijuana Stock Losers -...
September 10, 2018
5 of Today's Biggest Marijuana Stock Gainers -...
September 5, 2018
September 4, 2018
Aphria Partners with Danish Flower Producer
Namaste Announces Medical Cannabis Supply Agreemen...
Aurora Cannabis Closes $200 Million Debt Facility...
August 30, 2018
Roth Capital Upgraded Zynerba to a Buy Rating
August 16, 2017
Trading Marijuana Stocks With Ally Invest
August 7, 2017
7 Things To Know About Zynerba's Pipeline & Q2 Earnings Release
August 2, 2017
Zynerba Reaches Target Enrollment in Phase 2 Fragile X Study
June 8, 2017
Zynerba to Present at Jefferies Healthcare Conference
June 1, 2017
Insider Buying by CEO & CFO at Zynerba Pharmaceuticals
May 19, 2017